SCHEMBL17010754

SCHEMBL17010754

CC(C)OOc1ccccc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.56
HSD17B10 Q99714 7/20 0.56
HPGD P15428 5/20 0.56
ALDH1A1 P00352 8/20 0.55
ESR1 P03372 1/20 0.55
ITGB3 P05106 1/20 0.55
ITGA2B P08514 1/20 0.55
HMGB1 P09429 1/20 0.55
TSHR P16473 1/20 0.55
GGT1 P19440 1/20 0.55
PTGS1 P23219 1/20 0.55
PTGS2 P35354 1/20 0.55
BLM P54132 1/20 0.55
NAPRT Q6XQN6 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
HTT P42858 2/20 0.51
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
RECQL P46063 1/20 0.49
MAPT P10636 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9129863 0.87 KDM4E (0.54) KDM4EHSD17B10HPGDALDH1A1ESR1
SCHEMBL28984371 0.84 KDM4E (0.44) KDM4EHSD17B10HPGDALDH1A1ESR1
SCHEMBL5708147 0.83 KDM4E (0.51) KDM4EHSD17B10HPGDALDH1A1ESR1
SCHEMBL29010714 0.82 KDM4E (0.63) KDM4EHSD17B10HPGDALDH1A1ESR1
SCHEMBL9551796 0.82 KDM4E (0.49) KDM4EHSD17B10HPGDALDH1A1ESR1
SCHEMBL104892 0.81 IRAK4 (0.70) KDM4EHSD17B10HPGDALDH1A1ESR1
SCHEMBL10763308 0.79 IRAK4 (0.68) KDM4EHSD17B10HPGDALDH1A1ESR1
Bicarbonate SCHEMBL21811920 0.79 IRAK4 (0.68) KDM4EHSD17B10HPGDALDH1A1ESR1
Bicarbonate SCHEMBL29943521 0.79 IRAK4 (0.68) KDM4EHSD17B10HPGDALDH1A1ESR1
Benzene SCHEMBL27809575 0.79 IRAK4 (0.68) KDM4EHSD17B10HPGDALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110869349-A 2- { [2- (phenoxymethyl) pyridin-5-yl ] oxy } ethanamine derivatives and related compounds as pest control agents, e.g. for protecting plants 拜耳作物科学股份公司 2020-03-06 CN disclosed
CN-110691781-A Mesoionic imidazopyridines as pesticides 拜耳公司 2020-01-14 CN disclosed
EP-3104835-B1 PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION RECKITT BENCKISER LLC (US) 2019-02-13 EP disclosed
US-9877484-B2 Pulvurent effervescent topical treatment composition RECKITT BENCKISER LLC (US) 2018-01-30 US disclosed
US-20170006874-A1 PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION RECKITT BENCKISER LLC (US) 2017-01-12 US disclosed
EP-3104835-A1 PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION Reckitt Benckiser LLC (US) 2016-12-21 EP disclosed
WO-2015121659-A1 PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION RECKITT BENCKISER LLC (US) 2015-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170006874-A1 PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION SOST, FPR2, SHH KDM4E 4782/4885HSD17B10 2451/4885HPGD 1620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.